SCHEMBL1102608

SCHEMBL1102608

c1ccc(-c2cc(-c3ccccc3)cc(-c3c4ccccc4c(-c4ccccc4)c4ccncc34)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.43
CYP19A1 P11511 1/20 0.43
MAPK10 P53779 1/20 0.43
TNF P01375 1/20 0.42
PRKCZ Q05513 1/20 0.41
PRKD2 Q9BZL6 1/20 0.41
ALOX5 P09917 1/20 0.40
MAP2 P11137 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
RAD52 P43351 1/20 0.39
ACHE P22303 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
IKBKB O14920 1/20 0.38
AURKA O14965 1/20 0.38
CHUK O15111 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102499 0.98 NOTUM (0.45) NOTUMCYP19A1MAPK10TNFPRKCZ
SCHEMBL1102555 0.91 TNF (0.45) NOTUMCYP19A1MAPK10TNFPRKCZ
SCHEMBL1102701 0.91 TNF (0.47) NOTUMCYP19A1MAPK10TNFALOX5
SCHEMBL1102927 0.91 TNF (0.47) NOTUMCYP19A1MAPK10TNFALOX5
SCHEMBL1102728 0.91 NOTUM (0.48) NOTUMCYP19A1MAPK10TNFALOX5
SCHEMBL1102793 0.91 NOTUM (0.48) NOTUMCYP19A1MAPK10TNFALOX5
SCHEMBL1102483 0.91 NOTUM (0.48) NOTUMCYP19A1MAPK10TNFALOX5
SCHEMBL1102643 0.91 NOTUM (0.48) NOTUMCYP19A1MAPK10TNFALOX5
SCHEMBL1102490 0.91 TNF (0.48) NOTUMMAPK10TNFALOX5MAP2
SCHEMBL1102557 0.90 TNF (0.44) NOTUMCYP19A1MAPK10TNFPRKCZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 NOTUM 8/4885CYP19A1 1424/4885MAPK10 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.